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ABSTRACT 
Objective: The aim of presented study was to develop a high-performance liquid chromatography (HPLC) method with UV detection for 
simultaneous determination of ketoprofen, methyl paraben and propyl paraben in a gel formulation. 
Methods: The chromatography was carried out on a C18 
Results: Under these chromatographic conditions, the obtained retention times were approximately 2.41 min for methyl paraben, 3.33 min for 
propyl paraben and 7.41 min for ketoprofen. Analytical parameters specificity, linearity, accuracy, precision and robustness were determined by 
validation procedure and found to be satisfactory.  
(250 mm x 4.6 mm, 10 μm) column with methanol, acetonitrile and 1.5 % sodium acetate 
solution (15:35:50 v/v/v) as mobile phase, at a flow rate of 1.0 ml/min, with detection at 240 nm.  
Conclusion: Overall, the proposed method was found to be simple, rapid, precise and accurate for quality control of ketoprofen in the presence of 
preservatives in gel formulation. 
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INTRODUCTION 
Ketoprofen (KET) is a non-steroidal anti-inflammatory drug (NSAID) 
with well established analgesic and antipyretic properties used for 
the treatment of rheumatoid arthritis, osteoarthritis, ankylosing 
spondylitis and gout [1]. Although ketoprofen is poorly water 
soluble it is rapidly absorbed, metabolized and excreted, it causes 
some gastrointestinal complaints such as nausea, dyspepsia, 
diarrhea, constipation and some renal side effects like other NSAIDs. 
Topically applied NSAIDSs have several advantages in comparison 
with their systemically administrated counterparts. These drugs are 
simple for application and deliver high drug concentrations locally 
into affected tissues with limited side effects at the application site 
for prolonged periods [2]. 
Several types of analytical procedures have been proposed for the 
analysis of ketoprofen in pharmaceutical formulations. The 
procedures include capillary zone electrophoresis [3], UV-
spectrophotometry [4, 5], high-performance liquid chromatography 
[6,7], flow injection technique with hemiluminiscence [8], flow 
injection with UV-detection [9], polarography [10], potentiometry 
[11], and quantitative Fourier transformation infrared 
spectrophotometry [12]. European Pharmacopoeia recommends 
acid-base titration for analysis of ketoprofen in substance, UV-
spectrophotometry for its determination in capsules as well as liquid 
chromatography for assay in gel [13]. 
Methyl 4-hydroxybenzoate (methyl paraben) and propyl 4-
hydroxybenzoate (propyl paraben) are well-known preservatives 
used primarily for their bactericidal and fungicidal properties. 
Parabens are a group of alkyl esters of p-hydroxybenzoic acid, 
having a low toxicity profile and a long history of use. It readily 
absorb from the gastrointestinal tract or through the skin [14]. The 
use of methyl paraben is toxic at higher concentrations due to 
estrogenic effect [15]. The estrogenic activity of parabens increases 
with the length of the alkyl group and it is well known that propyl 
paraben is estrogenic to a certain degree as well [16].  
The determination of these substances in pharmaceuticals and 
cosmetics is important in quality control, especially considering the 
numerous reports of allergic reactions caused by preservatives. 
Some methods of analysis of investigated parabens either alone or in 
some other formulations are available including HPLC [17-25], solid 
phase extraction HPLC [26, 27], HPLC-MS [28]. 
Simultaneous determination of both parabens and ketoprofen is 
reported by several authors [29-33]. 
The aim of this paper was to develop a specific, precise and accurate 
chromatographic method able to be applied in quality control for the 
determination of ketoprofen in gel formulation in the presence of 
both preservatives methyl- and propyl parabens. 
MATERIALS AND METHODS 
Chemicals and Reagents 
Ketoprofen, methyl- and propyl parabens were purchased from 
Sigma-Aldrich (Germany) as standards. A ketoprofen gel containing 
2.5 % w/w active compound, 1 % w/w methyl paraben and 0.1 % 
w/w propyl paraben was obtained commercially. LC-grade methanol 
and acetonitrile were supplied from Merck (Germany). All other 
chemical reagents were of analytical grade. 
Instrumentation and chromatographic conditions 
Chromatographic separation was performed on modular HPLC system 
LC-10A Shimadzu (Japan) arranged with a LC-10A pump, solvent 
degasser DGU-3A, Rheodyne injector, column oven CTO-10A, SPD-M10A 
fixed wavelength detector and communication bus module CBM-10A. A 
LiChrosorb C18
Preparation of reference solutions 
, 250 mm x 4.6 mm, 10 μm column was used as a 
stationary phase. The components were separated isocratically with a 
mobile phase consisting of 15 volumes methanol, 35 volumes 
acetonitrile and 1.5 % sodium acetate solution at a flow rate of 1.0 
ml/min. The analysis was carried out at an ambient temperature and 
injection volume was 20 μl. The UV detector was set at 240 nm. 
Reference solution (a): The solution was prepared by dissolving 20.0 
mg of accurately weighed methyl paraben in methanol in a 50.0 ml 
volumetric flask (C=400 µg/ml).  
Reference solution (b): The solution was prepared by dissolving 20.0 
mg of accurately weighed propyl paraben in methanol in a 100.0 ml 
volumetric flask (C=200 µg/ml).  
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Working reference solution: The solution was prepared by 
dissolving of accurately weighed 25.0 mg ketoprofen in the first step 
and in the second step by diluting 25.0 ml of reference solution (a) 
and 5.0 ml of reference solution (b) with methanol into a 50.0 ml 
volumetric flask. The concentrations of the investigated compounds 
in working reference solution were as follows: ketoprofen – 500 
µg/ml, methyl paraben – 200 µg/ml and propyl paraben – 20 µg/ml, 
respectively. 
Sample preparation 
2 ml (accurately measured) of ketoprofen gel corresponding to 50 
mg ketoprofen, 20 mg methyl paraben and 2 mg propyl paraben 
were transferred to a 20 ml volumetric flask. Ten ml of methanol 
were added and the flask was placed in an ultrasonic bath for 20 
min. After cooling at the room temperature, the flask was filled with 
methanol to the volume mark, and the sample was centrifuged at 
2000 rpm for 10 min. Five ml of the clear centrifugate was 
transferred to a 25 ml volumetric flask, and filled with mobile phase 
to the volume mark. After filtration through a 0.45 mm membrane 
filter, an aliquot of the sample solution was injected into the HPLC 
column. 
Validation procedure 
The analytical method developed was validated with respect to 
specificity, precision, accuracy, robustness and sensitivity. 
Specificity 
The ability of an analytical method to unequivocally assess the 
analyte in the presence of other components can be demonstrated 
by evaluating specificity. The specificity of the method was evaluated 
by assessing interference from excipients in the pharmaceutical 
dosage form prepared as a placebo solution. 
Linearity and range 
The linearity of the method was determined at six concentration 
levels ranging from 125 to 1000 µg/ml for ketoprofen, from 50 to 
400 µg/ml for methylparaben and from 5 to 40 µg/ml for propyl 
paraben. The calibration curves were constructed by plotting peak 
areas versus concentrations of investigated compounds, and the 
regression equations were calculated. Each response was the 
average of three determinations. 
Precision 
Intraday precision (repeatability) was calculated using two 
concentrations of KET (250, 500 μg/ml), methyl paraben (100, 200 
μg/ml) and propyl paraben (10, 20 μg/ml) in triplicate using 
proposed methods. The inter day precision (reproducibility) was 
repeated three times on three different days for analysis of two 
different concentration (250:100:10, 500:200:20 μg/ml) for 
analyzed drugs.  
Accuracy 
Accuracy of the method was evaluated by standard addition 
technique, which was performed by addition of known amounts of 
pure ketoprofen and both parabens to known concentrations of gel 
and analysed by proposed methods in triplicate.  
Robustness 
Thе robustness of the method is a measure of the capacity to remain 
unaffected by small variations in method parameters and provides 
indication of its reliability during normal usage. Robustness of the 
analytical procedure was studied by deliberately varying parameters 
like analytical wavelength (±2 nm) and flow rate (±0.2 ml/min). 
Column-to-column reproducibility was also checked by using a C18 
column of different make (Nucleosil) with same dimension. 
RESULTS AND DISCUSSION 
Fig. 1, showed that under the experimental chromatographic 
conditions ketoprofen, methyl paraben and propyl paraben were 
completely separated one from each other. In the chromatogram of 
blank solution there are no interfering peaks at the retention times 
of the investigated peaks. This indicated that the method is selective 
and can be used for identification and simultaneous quantification of 




Fig. 1: Chromatogram of working standards: methyl paraben, 
propyl paraben and ketoprofen 
 
Retention times, number of theoretical plates and tailing factors 
obtained by using of the HPLC method were listed in Table 1. 
 









2.41 3.33 7.41 
Tailing factor 0.91 0.89 0.90 
Theoretical plates 2578 1354 1523 
 
Calibration and linearity 
We prepared a series of 5 calibration solutions with a concentration 
range shown in Table 2. It was found that response (peak area) was 
proportional to concentration over the ranges tested with 
correlation coefficients greater than 0.9996. Calibration plot data 
slope (a), intercept (b), and correlation coefficient (r) were listed in 
Table 2. 
 








50-400 5-40 125-1000 
Slope 2456.8 34111.7 47854.4 
Intercept 678.1 -946.4 7845.1 
Correlation coefficient 
(r) 
0.9996 0.9999 0.9998 
 
Precision 
The values of % RSD (Table 3) for KET, MP and PP were found to be 
in the range from 0.32 to 0.87 indicating good repeatability and 
reproducibility of the analytical procedure. 
Robustness 
It was found that the elution order and resolution for both 
components were not significantly affected by small variation of the 
conditions. Results from study of the robustness of the method were 
listed in Table 5. 
Limit of detection and limit of quantification 
The limits of quantification (LOQ) and limit of detection (LOD) were 
evaluated based on signal-to-noise ratios by serial dilution of 
working reference solution. The LOQs for ketoprofen, methyl 
paraben and propyl paraben were found to be 1.0, 0.8 and 0.5 µg/ml 
respectively; the LODs – 0.2, 0.1 and 0.05 µg/ml, respectively. 
 
 
Table 3: Precision of the method 
Precision Amount taken (μg/ml) % Mean* % RSD 
KET MP PP KET MP PP KET MP PP 
Intra day 250 100 10 99.56 100.5 99.61 0.36 0.32 0.54 
Intra day 500 200 20 100.1 100.2 100.9 0.65 0.61 0.61 
Inter day 250 50 10 99.48 99.89 99.81 0.84 0.56 0.38 
Inter day 500 150 20 99.75 99.52 99.62 0.78 0.87 0.42 
*Mean of three determinations 
 
Results presented in Table 4 indicated good accuracy and showed no interference from tablet excipients. 
 
Table 4: Recovery studies of ketoprofen and parabens 











125.0 625.7±1.50 0.24 
250.0 749.8±1.98 0.26 





50.00 248.4±0.95 0.38 
100.0 297.1±0.98 0.33 





5.00 24.81±0.25 1.01 
10.00 29.68±0.31 1.04 
15.0 35.87±0.28 0.78 
*Average value of three determinations, RSD is relative standard deviation 
 
Table 5: Robustness parameters of LC method 
Factor Level ketoprofen methyl paraben propyl paraben 
Analytical wavelength  Assay, % % RSD Assay, % % RSD Assay, % % RSD 
238 -2 99.84 0.54 100.0 0.65 98.8 0.98 
240 0 100.5 0.48 99.65 0.93 99.6 1.05 
242 +2 99.21 0.97 99.48 0.92 99.1 0.87 
Flow rate of mobile phase        
0.8 -0.2 98.79 1.24 98.70 0.64 98.2 0.56 
1.0 0 99.36 0.98 101.0 0.89 99.6 0.85 
1.2 +0.2 99.25 0.97 99.82 0.97 99.8 1.21 
Stationary phase        
Nucleosil C 18 - 101.2 1.08 99.81 0.91 99.1 1.04 
LiChrosorb C18 - 99.89 0.84 99.55 0.98 99.6 0.95 
 
CONCLUSION 
The validated RP-LC method developed here proved to be simple, 
specific, accurate, precise, sensitive and robust. It can successfully 
used for routine analysis of ketoprofen in the presence of described 
preservatives in gel formulation without any interference from 
common excipients. 
CONFLICT OF INTERESTS  
Declared None  
REFERENCES 
1. Goodman, Gilman's. The pharmacological basis of therapeutics: 
Tenth edition, New York 2001;10:2045. 
2. Rajendra R, Chetan C, Rajesh N, Manohar D. Ketoprofen: In-
vitro release and percutaneous absorption in rats through 
polymeric gels. Der Pharm Sin 2013;4:116-20. 
3. Blanko M, Coello J, Iturriaga H, Maspoch S, Perez-Maseda C. 
Chiral and nonchiral determination of ketoprofen in 
pharmaceuticals by capillary zone electrophoresis. J 
Chromatogr A 1998;799:301-7.  
4. Kormosh Z, Hunka I, Basel Y. Spectrophotometric determination of 
ketoprofen and its application in pharmaceutical analysis. Acta Pol 
Pharm-Drug Res 2009;66:3-9. 
5. El-Sadec M, El-Adi S, Abou-Kull M. Spectrophotometric 
determination of ketoprofen in pharmaceutical preparations by 
means of charge transfer complex formation. Talanta 
1993;40:585-8. 
6. Wong C, Yeh M, Wang D. High-performance liquid 
chromatographic determination of ketoprofen in 
pharmaceutical dosage forms and plasma. J Liquid 
Chromatography 1992;15:1215-25. 
7. Bempong D, Bhattacharyya L. Development and validation of a 
stability-indicating high-performance liquid chromatographic 
assay for ketoprofen topical penetrating gel. J Chromatogr A 
2005;1073:341-6. 
8. Zhuang Y, Cao D, Ge D. Flow injection analysis of ketoprofen 
based on the order transform second chemiluminiscence 
reaction. Spectrochim Acta part B 2012;85:139-44. 
9. Aboul-Enein H, Dal A, Tuncel M. A validated method 
development for ketoprofen by a flow-injection analysis with 
UV-detection and its application to pharmaceutical 
formulations. Il Pharm 2003;58:419-22. 
10. Amankwa L, Chatten L. Electrochemical reduction of ketoprofen 
and its determination in pharmaceutical dosage forms by 
differential-pulse polarography. Anal 1984;109:57-60.  
11. Kormosh Z, Hunka I, Basel Y, Matviychuk O. Potentiometric 
determination of ketoprofen and piroxicam at a new PVC 
electrode based on ion associates of Rhodamine 6G. Materials 
Sci Eng C 2010;30:997-1002. 
12. Overbeke A, Baeylus W, Van der Bossche W. Quantitative Fourier 
transform infrared attenuated total reflectance analysis of 
Tsvetkova et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 11, 199-202 
202 
ketoprofen in some pharmaceutical formulations. Spectrosc 
1995;9:121-30. 
13. European Pharmacopoeia, 5th ed. Council of Europe, 
Strasbourg; 2007. 
14. Soni M, Taylor S, Greenberg N, Burdock G. Evaluation of the 
health aspects of methyl paraben: a review of the published 
literature. Food Chem Toxicol 2002;40:1335-73. 
15. Wei G. Toxicity and estrogen effects of methyl paraben on 
drosophila melanodaster. Food Sci 2009;30:252-4. 
16. Cashman A, Warshaw E. Parabens: a review of epidemiology, 
structure, allergenicity, and hormonal properties. Dermatitis 
2005;16:57-66. 
17. Shabir GA. A new validated HPLC method for the simultaneous 
determination of 2-phenoxyethanol, methylparaben, 
ethylparaben and propylparaben in a pharmaceutical gel. Indian J 
Pharm Sci 2010;72:421-5. 
18. Atemnkeng MA, Marchand E, Plaizier-Vercammen J. Assay of 
artemether, methylparaben and propylparaben in a formulated 
paediatric antimalarial dry suspension. J Pharm Biomed Anal 
2007;43:727-32. 
19. Satinsky D, Huclova J, Ferreira RL, Montenegro MC, Solich P. 
Determination of ambroxol hydrochloride, methylparaben and 
benzoic acid in pharmaceutical preparations based on 
sequential injection technique coupled with monolithic column. 
J Pharm Biomed Anal 2006;40:287-93. 
20. Ali MS, Ghori M, Khatri AR. Stability indicating simultaneous 
determination of domperidone (DP), methylparaben (MP) and 
propylparaben by high performance liquid chromatography 
(HPLC). J Pharm Biomed Anal 2006;41:358-65. 
21. Matysova L, Hajkova R, Sicha J, Solich P. Determination of 
methylparaben, propylparaben, triamcinolone acetonide and 
its degradation product in a topical cream by RP-HPLC. Anal 
Biol Chem 2003;376:440-3. 
22. Kreuz DM, Howard AL, Ip D. Determination of indinavir, potassium 
sorbate, methylparaben, and propylparaben in aqueous pediatric 
suspensions. J Pharm Biomed Anal 1999;19:725-35. 
23. Hajkova R, Solich P, Dvorak J, Sicha J. Simultaneous 
determination of methylparaben, propylparaben, hydrocortisone 
acetate and its degradation products in a topical cream by RP-
HPLC. J Pharm Biomed Anal 2003;32:921-7. 
24. Ali MS, Chaudhary RS, Takieddin MA. Simultaneous 
determination of metronidazole benzoate, methylparaben, and 
propylparaben by high performance liquid chromatography. 
Drug Dev Ind Pharm 1999;25:1143-7. 
25. Kokoletsi MX, Kafkala S, Tsiaganis M. A novel gradient HPLC 
method for simultaneous determination of ranitidine, 
methylparaben and propylparaben in oral liquid 
pharmaceutical formulation. J Pharm Biomed Anal 
2005;38:763-7. 
26. Pongcharoenkiat N, Wittayanukulluk A, Hem SL. Determination 
of methylparaben in o/w emulsions by solid-phase extraction 
and high performance liquid chromatography. J Cosmet Sci 
2003;54:47-52. 
27. Rebbeck C, Hammond R, Wong J, Nair L, Raghavan N. Solid 
phase extraction and HPLC analysis of methylparaben and 
propylparaben in a concentrated antibiotic suspension. Drug 
Dev Ind Pharm 2006;32:1095-102. 
28. Ma M, DiLollo A, Mercuri R, Lee T, Bundang M. HPLC and LCMS 
studies of the transesterification reaction of methylparaben 
with twelve 3-to 6-carbon sugar alcohols and propylene glycol 
and the isomerization of the reaction products by acyl 
migration. J Chromatogr Sci 2002;40:170-7. 
29. Mannucci C, Bertini J, Cocchini A, Salvagninip F, Triolo A. High 
performance liquid chromatography simultaneous quantitation 
of ketoprofen and parabens in a commercial gel formulation. J 
Liquid Chrom 1992;15:327-35. 
30. .Dvořák J, Hájková R, Matysová L, Nováková L, Koupparis MA, 
Solich P. Simultaneous HPLC determination of ketoprofen and 
its degradation products in the presence of preservatives in 
pharmaceuticals. J Pharm Biomed Anal 2004;36:625-9. 
31. Labbozzetta S, Valvo L, Bertocchi P, Alimonti S, Gaudiano M, 
Manna L. Focused Microwave-Assisted extraction and lc 
determination of ketoprofen in the presence of preservatives in 
a pharmaceutical cream formulation. Chromatographia 
2009;69:365-8. 
32. Blanco M, Coello J, Iturriaga H, Maspoch S, Alaoui-Ismaili S. UV-
Spectrophotometric determination of ketoprofen and paraben 
in a gel preparation by partial least-squares calibration. 
Fresenius' J Anal Chem 1997;357:967-72. 
33. Safra J, Pospisilova M. Separation and determination of 
ketoprofen, methylparaben and propylparaben in 
pharmaceutical preparation by micellar electrokinetic 
chromatography. J Pharm Biomed Anal 2008;48:452-5. 
 
